![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Enrolling by invitation |
Unique ID issued by UMIN | UMIN000040249 |
Receipt No. | R000045917 |
Scientific Title | Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer |
Date of disclosure of the study information | 2020/05/01 |
Last modified on | 2020/04/27 |
Basic information | ||
Public title | Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer | |
Acronym | Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer | |
Scientific Title | Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer | |
Scientific Title:Acronym | Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer | |
Region |
|
Condition | ||
Condition | Breast cancer | |
Classification by specialty |
|
|
Classification by malignancy | Malignancy | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To investigate the possibility of de-escalation therapy omitting postoperative radiation therapy after conservative surgery in patients with primary invasive breast cancer who have no lymph node metastasis and lymph-vascular invasion and low risk of local recurrence |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Incidence of invasive cancer in the preserved breast (limited to the first recurrence) |
Key secondary outcomes | 1. Incidence of cancer in the preserved breast
2. Incidence of true recurrence (TR) and new primary lesion (NP) 3. Recurrence-free survival rate 4. Overall survival rate 5. Search for risk factors for ipsilateral breast cancer (Age, ER status, PgR status, HER2 status, tumor diameter, Nuclear grade) 6. Incidence of contralateral breast cancer 7. Incidence of distant metastases 8. Incidence of local recurrence rate 9. Incidence of symptomatic pneumonitis 10. Incidence rate of symptomatic cardiac dysfunction 11. Incidence and degree of skin disorders |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Non-randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Uncontrolled |
Stratification | NO |
Dynamic allocation | NO |
Institution consideration | |
Blocking | NO |
Concealment | No need to know |
Intervention | ||
No. of arms | 1 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Omission of radiation therapy after breast-conserving surgery | |
Interventions/Control_2 | ||
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Female | |||
Key inclusion criteria | 1) Histologically diagnosed invasive breast cancer (irrespective of histological type).
2) TNM classification: pT1-T2pN0 3) Partial mastectomy is performed by vertical resection in which lateral stump can be diagnosed. 4) There is no residual cancer on the skin or pectoralis major muscle. 5) Partial mastectomy specimens are pathologically examined at intervals of 5 mm, and an experienced breast pathologist has concluded complete resection (the distance from the lateral stump to the cancer cells is longer than 5 mm). 6) Histologically no lymph-vascular invasion detected. 7) Age at registration is 20 years or older 8) Performance status (ECOG) is 0 or 1. 9) Main organ functions are maintained. 10) Patients have given their consent to participate in the study through the documents. |
|||
Key exclusion criteria | 1) Bilateral breast cancer cases
2) Double cancer cases (within 5 years after completion of treatment) 3) Cases of additional resection during surgery 4) Cases of excisional biopsy 5) Patients who have not undergone standard surgery on lymph nodes 6) BRCA mutation positive cases 7)When the doctor in charge determines that it is inappropriate |
|||
Target sample size | 600 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Cancer Institute Hospital of Japanese Foundation for Cancer Research | ||||||
Division name | Department of Breast Surgical Oncology, Breast Oncology Center | ||||||
Zip code | 1358550 | ||||||
Address | 3-8-31, Ariake, Koto-ku, Tokyo | ||||||
TEL | 0335200111 | ||||||
takayuki.ueno@jfcr.or.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Cancer Institute Hospital of Japanese Foundation for Cancer Research | ||||||
Division name | Department of Breast Surgical Oncology, Breast Oncology Center | ||||||
Zip code | 1358550 | ||||||
Address | 3-8-31, Ariake, Koto-ku, Tokyo | ||||||
TEL | 0335200111 | ||||||
Homepage URL | |||||||
takayuki.ueno@jfcr.or.jp |
Sponsor | |
Institute | Department of Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research |
Institute | |
Department |
Funding Source | |
Organization | None |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Medical Research Ethics Review Committee, Japanese Foundation for Cancer Research |
Address | 3-8-31, Ariake, Koto-ku, Tokyo |
Tel | 0335200111 |
med.shinsa@jfcr.or.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | がん研究会有明病院 乳腺センター 乳腺外科(東京都) |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Enrolling by invitation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045917 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |